Fig. 2From: Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trialReduction in pain scores from baseline to week 4 in the OXN-CR and OX-CR groups (full analysis set, FAS). The error bars represent standard deviation (SD). NRS numeric rating scaleBack to article page